Zhengye Biotechnology Holding (ZYBT) Inventory (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has reported Inventory for 3 consecutive years, with $5.5 million the latest figure, recorded in Q4 2025.

• Quarterly Inventory fell 31.87% year-over-year to $5.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.5 million (down 31.87% YoY) and the FY2025 annual result came in at $5.6 million, down 29.79% from the prior year.
• Inventory slipped to $5.5 million in Q4 2025 per ZYBT's latest filing, from $7.5 million in the prior quarter.
• Over the last five years, Inventory for ZYBT reached as high as $8.1 million in Q4 2024 and fell as low as $5.5 million in Q4 2025.
• A 3-year average of $7.3 million and a median of $7.8 million in 2023 frame the typical range for Inventory.
• Annual changes were most pronounced in 2024 — Inventory rose 0.1% — and 2025, when it tumbled 31.87%.
• Year by year, Inventory stood at $8.1 million in 2023, then grew by 0.1% to $8.1 million in 2024, then tumbled by 31.87% to $5.5 million in 2025.
• According to Business Quant data, Inventory over the past three periods registered $5.5 million, $7.5 million, and $8.1 million for Q4 2025, Q2 2025, and Q4 2024 respectively.